Afsal Kolloli

748 total citations
31 papers, 522 citations indexed

About

Afsal Kolloli is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Afsal Kolloli has authored 31 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 11 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Afsal Kolloli's work include Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Afsal Kolloli is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Afsal Kolloli collaborates with scholars based in United States, India and South Africa. Afsal Kolloli's co-authors include Selvakumar Subbian, Periasamy Selvaraj, M. Harishankar, Ranjeet Kumar, Pooja Singh, Paramasivam Selvaraj, Yuri Bushkin, Sanjay Tyagi, Lanbo Shi and Gilla Kaplan and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Afsal Kolloli

30 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afsal Kolloli United States 13 276 185 152 130 74 31 522
Ae‐Ran Choi South Korea 18 143 0.5× 99 0.5× 186 1.2× 92 0.7× 45 0.6× 33 566
Tapas Patra United States 14 166 0.6× 80 0.4× 211 1.4× 117 0.9× 21 0.3× 29 559
Nathalie Court France 10 229 0.8× 190 1.0× 150 1.0× 279 2.1× 13 0.2× 11 549
Anne Marstad Norway 7 108 0.4× 151 0.8× 201 1.3× 95 0.7× 16 0.2× 12 394
Diana L. Bonilla United States 11 54 0.2× 212 1.1× 205 1.3× 233 1.8× 18 0.2× 18 593
Wan‐Chung Hu Taiwan 12 139 0.5× 55 0.3× 118 0.8× 164 1.3× 38 0.5× 28 464
Estela Isabel Bini Mexico 11 143 0.5× 98 0.5× 59 0.4× 66 0.5× 36 0.5× 19 339
Mohanalaxmi Indramohan United States 11 116 0.4× 109 0.6× 389 2.6× 434 3.3× 33 0.4× 15 768
Ji Hoon Jeon South Korea 13 206 0.7× 74 0.4× 198 1.3× 82 0.6× 22 0.3× 26 561
Magdalena Kowalewicz‐Kulbat Poland 16 158 0.6× 116 0.6× 161 1.1× 276 2.1× 18 0.2× 43 616

Countries citing papers authored by Afsal Kolloli

Since Specialization
Citations

This map shows the geographic impact of Afsal Kolloli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsal Kolloli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsal Kolloli more than expected).

Fields of papers citing papers by Afsal Kolloli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afsal Kolloli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsal Kolloli. The network helps show where Afsal Kolloli may publish in the future.

Co-authorship network of co-authors of Afsal Kolloli

This figure shows the co-authorship network connecting the top 25 collaborators of Afsal Kolloli. A scholar is included among the top collaborators of Afsal Kolloli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afsal Kolloli. Afsal Kolloli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Ranjeet, Santhamani Ramasamy, Afsal Kolloli, et al.. (2024). Modulations of Homeostatic ACE2, CD147, GRP78 Pathways Correlate with Vascular and Endothelial Performance Markers during Pulmonary SARS-CoV-2 Infection. Cells. 13(5). 432–432. 2 indexed citations
2.
Kolloli, Afsal, Ranjeet Kumar, Vishwanath Venketaraman, & Selvakumar Subbian. (2024). Immunopathology of Pulmonary Mycobacterium tuberculosis Infection in a Humanized Mouse Model. International Journal of Molecular Sciences. 25(3). 1656–1656. 4 indexed citations
3.
Ganusov, Vitaly V., Afsal Kolloli, & Selvakumar Subbian. (2024). Mathematical modeling suggests heterogeneous replication of Mycobacterium tuberculosis in rabbits. PLoS Computational Biology. 20(11). e1012563–e1012563. 1 indexed citations
4.
Kolloli, Afsal, et al.. (2023). A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection. Frontiers in Immunology. 14. 1270414–1270414. 5 indexed citations
5.
Campbell, Elliot, Afsal Kolloli, Santhamani Ramasamy, et al.. (2023). A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response. Vaccines. 11(4). 832–832. 1 indexed citations
6.
Owens, James, Aram Yegiazaryan, Afsal Kolloli, et al.. (2023). Liposomal Glutathione Supplementation Mitigates Extrapulmonary Tuberculosis in the Liver and Spleen. Frontiers in Bioscience-Elite. 15(3). 15–15. 4 indexed citations
7.
Subbian, Selvakumar, Ranjeet Kumar, Afsal Kolloli, & Pooja Singh. (2023). The nature of the stimulant differentially impacts the innate memory response of monocytes to Mycobacterium tuberculosis. The Journal of Immunology. 210(Supplement_1). 72.22–72.22. 1 indexed citations
8.
Ravindran, Resmi, Cindy B. McReynolds, W. L. William Chang, et al.. (2023). Dynamics of temporal immune responses in nonhuman primates and humans immunized with COVID-19 vaccines. PLoS ONE. 18(10). e0287377–e0287377.
9.
Owens, James, Ruoqiong Cao, Afsal Kolloli, et al.. (2022). Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs. Antioxidants. 11(4). 673–673. 11 indexed citations
10.
Ramasamy, Santhamani, Afsal Kolloli, Ranjeet Kumar, et al.. (2022). Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection. Biomedicines. 10(6). 1343–1343. 7 indexed citations
11.
Merolli, Antonio, Santhamani Ramasamy, Afsal Kolloli, et al.. (2022). An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy. Scientific Reports. 12(1). 3794–3794. 18 indexed citations
12.
Cao, Ruoqiong, Kimberly To, James Owens, et al.. (2021). Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection. BioMolecular Concepts. 12(1). 46–54. 9 indexed citations
13.
Kumar, Ranjeet, Afsal Kolloli, & Selvakumar Subbian. (2021). Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration. Methods and Protocols. 4(1). 18–18. 6 indexed citations
14.
Cao, Ruoqiong, Afsal Kolloli, Ranjeet Kumar, et al.. (2021). Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection. Applied Sciences. 11(17). 8274–8274. 12 indexed citations
15.
Kolloli, Afsal, Pooja Singh, G. Marcela Rodríguez, & Selvakumar Subbian. (2019). Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection. Journal of Clinical Medicine. 8(8). 1155–1155. 10 indexed citations
16.
Kumar, Ranjeet, Pooja Singh, Afsal Kolloli, et al.. (2019). Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection. Frontiers in Molecular Biosciences. 6. 105–105. 65 indexed citations
17.
Kolloli, Afsal, et al.. (2014). Effect of Vitamin D 3 on Antimicrobial Peptide Gene Expression in the Neutrophils of Pulmonary Tuberculosis Patients. Current Science. 107(2). 259–262. 1 indexed citations
18.
Harishankar, M., et al.. (2014). Effect of 1,25-Dihydroxy Vitamin D3 on Toll-like Receptor Gene Expression in Neutrophils of Pulmonary Tuberculosis. Current Science. 107(4). 642–645. 1 indexed citations
19.
Harishankar, M., et al.. (2014). 1,25-Dihydroxy vitamin D3 downregulates pro-inflammatory cytokine response in pulmonary tuberculosis. International Immunopharmacology. 23(1). 148–152. 33 indexed citations
20.
Selvaraj, Periasamy, Kalichamy Alagarasu, Brijendra Singh, & Afsal Kolloli. (2011). CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India. International Journal of Immunogenetics. 38(5). 397–402. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ae‐Ran Choi Breakdown of academic impact, for papers by Tapas Patra Breakdown of academic impact, for papers by Nathalie Court Breakdown of academic impact, for papers by Anne Marstad Breakdown of academic impact, for papers by Diana L. Bonilla Breakdown of academic impact, for papers by Wan‐Chung Hu Breakdown of academic impact, for papers by Estela Isabel Bini Breakdown of academic impact, for papers by Mohanalaxmi Indramohan Breakdown of academic impact, for papers by Ji Hoon Jeon Breakdown of academic impact, for papers by Magdalena Kowalewicz‐Kulbat
Rankless by CCL
2026